Posted On: 01/14/2015 11:17:50 PM
Post# of 30067
Re: gobears1985 #15178
Quote:
Typical and predictable over-reaction by many here to information they don't understand.
Not sure people even understand what "Top-Line results" are. Gerald said the data will be published.
Quote:
"Amarantus intends to publish data from this study, as well as previously reported data, at prestigious scientific congresses and in peer-reviewed journals throughout the course of 2015."
Aug. 1, 2014 - Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R)
http://ir.amarantus.com/company-news/detail/1...mpro-testr
Oct. 9, 2014 - Amarantus Announces Positive LP-002 Data for Alzheimer's Blood Diagnostic LymPro Test(R)
http://ir.amarantus.com/company-news/detail/1...mpro-testr
Dec. 29, 2014 - Amarantus to Present LP-002 Data for Alzheimer's Blood Diagnostic LymPro Test(R) at Biotech Showcase 2015 Conference on January 14, 2015
Quote:
"Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics in Alzheimer's disease and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, announced it will be presenting a corporate overview including top-line results of its expanded LP-002 study of the Lymphocyte Proliferation Test (LymPro Test®) blood diagnostic for Alzheimer's disease (AD) at Biotech Showcase 2015."
(0)
(0)
